Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-2 of 2
Keywords: Immune checkpoint inhibitors
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
Aykhan Isgandarov, Mulham Al-Nader, Umut Ulas Yesilyurt, Yahor Katayeu, Osama Mahmoud, Claudia Kesch, Boris Hadaschik, Viktor Grünwald, Christopher Darr
Journal:
Urologia Internationalis
Urol Int (2026)
Published Online: 09 June 2026
...Aykhan Isgandarov; Mulham Al-Nader; Umut Ulas Yesilyurt; Yahor Katayeu; Osama Mahmoud; Claudia Kesch; Boris Hadaschik; Viktor Grünwald; Christopher Darr Introduction: Treatment of metastatic urothelial carcinoma (mUC) has evolved. The efficacy of chemotherapy (CT) and immune checkpoint inhibitors...
Journal Articles
Journal:
Urologia Internationalis
Urol Int (2023) 107 (8): 755–771.
Published Online: 14 July 2023
... major clusters were explored based on the reference co-citation analysis. From 2000 to 2022, the research hot spots have undergone two dramatic shifts during 2006 and 2019, respectively, relevant topics were TKI and TKI combined with immune checkpoint inhibitors (CPIs). At present, the research hot...
